Newventureiq LLC Profile last edited on: 8/5/2020
CAGE: 7WWE7
UEI: NNNQSVLWLSA5
Business Identifier: Deep Learning models 
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
Location Information
Location: Single
Congr. District: 01
County: St. Louis city
Congr. District: 01
County: St. Louis city
Public Profile
Newventureiq LLC develops Deep Learning technology for medical applications. They are developing technology for the assessment of kidney disease and handwrtiting disorders.
Extent of SBIR involvement
Synopsis: Awardee Business Condition
Employee Range
1-4Revenue Range
Less than .5MVC funded?
NoPublic/Private
Privately HeldStock Info
----IP Holdings
N/AAwards Distribution by Agency
Most Recent SBIR Projects
| Year | Phase | Agency | Total Amount | |
|---|---|---|---|---|
| 2023 | 1 | NIH | $403,240 | |
| Project Title: Clinical biomarker for early prediction of chemotherapy-induced peripheral neuropathy | ||||
| 2022 | 1 | NIH | $279,951 | |
| Project Title: A Deep Learning Model to Quantify Arteriosclerosis in Donor Kidney Biopsies | ||||
| 2021 | 2 | NIH | $1,800,818 | |
| Project Title: A Deep Learning Model to Improve Pathologist Interpretation of Donor Kidney Biopsies | ||||
| 2019 | 1 | NIH | $284,282 | |
| Project Title: Rapid High-Resolution Typing of Human Leukocyte Antigen Genes by Nanopore Sequencing for Transplantation | ||||
| 2019 | 1 | NIH | $99,995 | |
| Project Title: Measuring Activities of Daily Living in Stroke Patients with Motion Artificial Intelligence | ||||
Key People / Management
Victoria Swamidass -- CEO
Joseph P Gaut
Simon Haroutounian
Chang Liu
Benjamin Allen Philip
Joseph P Gaut
Simon Haroutounian
Chang Liu
Benjamin Allen Philip
Company News
There are no news available.
